Skip to main content

Table 3 Associations between MRI-detected inflammation and achieving DMARD-free sustained remission over time

From: Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study

Type of MRI-detected inflammation Univariable model HR (95% CI) Multivariable model 1a HR (95% CI) Multivariable model 2b HR (95% CI)
BME 0.99 (0.94–1.03) 0.96 (0.99–1.02) 1.00 (0.94–1.07)
Synovitis 1.03 (0.97–1.09) 1.04 (0.95–1.15) 1.00 (0.90–1.10)
Tenosynovitis 1.04 (0.99–1.10) 1.03 (0.95–1.11) 1.01 (0.94–1.08)
Total inflammation 1.01 (0.99–1.03)
  1. All HRs are per point increase of MRI-detected inflammation
  2. BME bone marrow edema, CI confidence interval, DMARD disease-modifying antirheumatic drug, HR hazard ratio, MRI magnetic resonance imaging
  3. aMultivariable model 1 includes MRI-detected BME, synovitis and tenosynovitis
  4. bMultivariable model 2 includes MRI-detected BME, synovitis and tenosynovitis as well as ACPA